Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer

Annals of Surgical Oncology
Vered StearnsTheodore N Tsangaris

Abstract

After neoadjuvant chemotherapy, women with locally advanced breast cancer (LABC) undergo a modified radical mastectomy or lumpectomy with axillary lymph node dissection (ALND) and radiotherapy. Sentinel lymphadenectomy (SL) is accepted for axillary evaluation in early breast cancer. We assessed the feasibility and predictive value of SL after neoadjuvant chemotherapy. Eligible women received neoadjuvant therapy for LABC and were scheduled to undergo a definitive surgical procedure. Vital blue dye SL was attempted followed by level I and II axillary dissection. SL was successful in 29 of 34 patients (detection rate, 85%). Thirteen patients (45%) had positive nodes, and eight (28%) had negative nodes on both SL and ALND. In five patients (17%), the sentinel node was the only positive node identified. Overall, there was a 90% concordance between SL and ALND. The false-negative rate and negative predictive value were 14% and 73%, respectively. Among the subgroup without inflammatory cancer, the detection and concordance rates were 89% and 96%, respectively. The false-negative rate was 6%, and the negative predictive value was 88%. SL after neoadjuvant chemotherapy may reliably predict axillary staging except in inflammatory breast ...Continue Reading

References

Jul 1, 1992·British Journal of Cancer·D IvensG T Royle
Mar 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B Fisher, E P Mamounas
May 1, 1996·Annals of Surgical Oncology·M Morrow
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A E GiulianoR Statman
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G BonadonnaM Zambetti
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B FisherH D Bear
Oct 1, 1998·The New England Journal of Medicine·D KragP Beitsch
Mar 2, 1999·Journal of the National Cancer Institute·U VeronesiD Scarpa
Apr 1, 1999·Cancer Investigation·S M Swain
Jun 11, 1999·Hematology/oncology Clinics of North America·F J Esteva, G N Hortobagyi
Mar 29, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A C Wolff, N E Davidson
Oct 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T M BreslinK K Hunt
Nov 15, 2000·CA: a Cancer Journal for Clinicians·E C HsuehA E Giuliano
Feb 24, 2001·Journal of the National Cancer Institute·V S EricksonK L Kahn
Apr 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M MorrowD Winchester

❮ Previous
Next ❯

Citations

Feb 7, 2007·Future Oncology·Judy C Boughey, Kelly K Hunt
Jun 18, 2014·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Paweł MurawaKarol Połom
Jun 24, 2014·Semergen·C Álvarez HernándezL Robles Díaz
Jan 13, 2005·Gynäkologisch-geburtshilfliche Rundschau·Christoph J RagethElisabeth Saurenmann
Jul 2, 2005·Gynäkologisch-geburtshilfliche Rundschau·Mathias K Fehr
Oct 29, 2003·Breast Cancer Research : BCR·Sharon H Giordano, Gabriel N Hortobagyi
Dec 20, 2005·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Conor D Collins
Jan 31, 2007·World Journal of Surgical Oncology·George M Filippakis, George Zografos
Oct 15, 2008·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Conor D Collins
Jan 22, 2010·World Journal of Surgical Oncology·Alessandra MascaroLucio Fortunato
Jul 7, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S DawoodM Cristofanilli
Oct 4, 2011·The Oncologist·Alice Ho, Monica Morrow
Oct 9, 2013·JAMA : the Journal of the American Medical Association·Judy C BougheyUNKNOWN Alliance for Clinical Trials in Oncology
Jun 10, 2011·Magyar onkologia·Zoltán MátraiMiklós Kásler
Apr 4, 2009·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Milan VisnjićGoran Dordević
Mar 5, 2004·Surgical Oncology·Steven D Trocha, Armando E Giuliano
May 20, 2009·Future Oncology·Barbara A Pockaj, Richard J Gray
May 5, 2012·World Journal of Surgery·Ashwini KumarIsmail Jatoi
Jun 28, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·L G EstévezI Tusquets
Aug 28, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A MilletF Dirbas
Nov 20, 2004·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Tadashi IkedaMasaki Kitajima
Nov 20, 2004·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Charles E CoxElisabeth Dupont
Nov 20, 2004·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Seok Hyung KangEun Sook Lee
Dec 5, 2003·Annals of Surgical Oncology·Hiram S Cody
Apr 9, 2004·Annals of Surgical Oncology·Emmanuel BarrangerEmile Darai
Nov 15, 2006·Annals of Surgical Oncology·Loic LelievreJocelyne Jacquemier
Sep 12, 2008·Annals of Surgical Oncology·Kandice E KilbrideLisa A Newman
Mar 17, 2010·Annals of Surgical Oncology·Alice Chung, Armando Giuliano
Feb 4, 2006·Current Treatment Options in Oncology·Farin Amersi, Nora M Hansen
Nov 20, 2012·Current Treatment Options in Oncology·Della Makower, Joseph A Sparano
Dec 11, 2003·Current Oncology Reports·Lisa A Newman
Jun 16, 2004·Langenbeck's Archives of Surgery·T SchulzeP M Schlag
Oct 16, 2004·Expert Review of Anticancer Therapy·Anees B Chagpar, Kelly M McMasters
Dec 4, 2009·Expert Opinion on Pharmacotherapy·Maria D IniestaSofia D Merajver
Jun 19, 2015·International Journal of Cancer. Journal International Du Cancer·Simone MocellinDonato Nitti
Feb 24, 2016·Asia-Pacific Journal of Clinical Oncology·Vinicius C Do NascimentoChristobel Saunders
Aug 7, 2013·Hematology/oncology Clinics of North America·Farin Amersi, Armando E Giuliano
Jan 7, 2005·The British Journal of Surgery·H CharfareA D Purushotham

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Nuclear Medicine and Molecular Imaging
Giuseppe TrifiròGiovanni Paganelli
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
E BayoM Algara
© 2022 Meta ULC. All rights reserved